Brind.
  1. Adagene Inc. announced strategic developments regarding its ADG126 therapy, including FDA alignment, a partnership with Sanofi, and collaboration with Merck's anti-PD-1 therapy.

Sanofi representative announced to join Adagene’s Scientific Advisory Board.

1 report, 0 independent Updated Jul 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Sanofi representative announced to join Adagene’s Scientific Advisory Board.

Who's involved

What this event is mainly about
Sanofi

Keep exploring

Part of

Adagene Inc. announced strategic developments regarding its ADG126 therapy, including FDA alignment, a partnership with Sanofi, and collaboration with Merck's anti-PD-1 therapy. All 2 developments

The entities involved

  • Sanofi

    company in Milan, Italy

    Nothing else this week.

Coverage

Newest first; wire copies grouped
  • Unknown outlet